1
|
Bachtarzi R, Boureau AS, Mascart C, Batard E, Montassier E, Bémer P, Bourigault C, Berrut G, de Decker L, Chapelet G. <p>Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing <em>Enterobacteriaceae</em></p>. Infect Drug Resist 2019; 12:1763-1770. [PMID: 31303771 PMCID: PMC6612047 DOI: 10.2147/idr.s200029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2018] [Accepted: 03/05/2019] [Indexed: 11/29/2022] Open
Abstract
Background The worldwide dissemination of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae has become a major health concern. Previous studies have shown that psychoactive drugs have intrinsic antimicrobial activity and may play a role in the dissemination of antibiotic resistance. The objective of this study was to assess the association between prescriptions for psychoactive drug and urine colonization with ESBL-producing Enterobacteriaceae. Subjects Ninety-five patients were included; 19 cases (urine colonization with an ESBL-producing Enterobacteriaceae) and 76 controls (urine colonization with non ESBL-producing Enterobacteriaceae); and were matched for age and gender. Methods A retrospective 1:4 matched case–control study design was used. All patients colonized with an Enterobacteriaceae isolate in Nantes University Hospital from March to November 2014, were screened before inclusion in the study. Prescriptions data for psychoactive drugs were collected from the electronic medical records. Univariate and multivariate conditional logistic regression analyses were performed. Results Thirty-seven patients (38.9%) were treated with psychoactive drugs, of whom 10 (52.6%) were in the ESBL-producing group and 27 (35.5%) were in the non-ESBL group. Mean (SD) age was 71.2 (23.1) years. In multivariate analyses, previous antimicrobial therapy within 6 months (OR=7.12, 95% CI 1.15–44.18; p=0.035) and previous colonization with an ESBL-producing organism (OR=44.87, 95% CI 1.26–1594.19; p=0.037) were associated with urine colonization with ESBL-producing Enterobacteriaceae. Conclusions Our findings revealed that a history of previous antimicrobial therapy and previous colonization with ESBL-producing organisms are important risk factors in an elderly population. Psychoactive drugs were not associated with urinary carriage of ESBL-producing Enterobacteriaceae. Further studies are required to explore the relationship between psychoactive drugs and colonization with ESBL-producing Enterobacteriaceae.
Collapse
Affiliation(s)
- Raphaële Bachtarzi
- Centre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, NantesF-44000, France
| | - Anne Sophie Boureau
- Centre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, NantesF-44000, France
| | - Charlotte Mascart
- Centre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, NantesF-44000, France
| | - Eric Batard
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance bacterienne), Institut de Recherche en Santé (IRS2), NantesF-44200, France
- Centre Hospitalier Universitaire de Nantes, Emergency Department, NantesF-44000, France
| | - Emmanuel Montassier
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance bacterienne), Institut de Recherche en Santé (IRS2), NantesF-44200, France
- Centre Hospitalier Universitaire de Nantes, Emergency Department, NantesF-44000, France
| | - Pascale Bémer
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance bacterienne), Institut de Recherche en Santé (IRS2), NantesF-44200, France
- Centre Hospitalier Universitaire de Nantes, Bacteriology Department, NantesF-44000, France
| | - Céline Bourigault
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance bacterienne), Institut de Recherche en Santé (IRS2), NantesF-44200, France
| | - Gilles Berrut
- Centre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, NantesF-44000, France
| | - Laure de Decker
- Centre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, NantesF-44000, France
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance bacterienne), Institut de Recherche en Santé (IRS2), NantesF-44200, France
| | - Guillaume Chapelet
- Centre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, NantesF-44000, France
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance bacterienne), Institut de Recherche en Santé (IRS2), NantesF-44200, France
- Correspondence: Guillaume ChapeletCentre Hospitalier Universitaire de Nantes, Clinical Gerontology Department, 1 Place Alexis-Ricordeau, NantesF-44000, FranceTel +33 24 016 5212Fax +33 24 016 5397Email
| |
Collapse
|